NO20023773D0 - Forbindelser anvendbare for behandling eller forhindring av en sykdom formidlet av alfa-2B-adrenoceptor - Google Patents

Forbindelser anvendbare for behandling eller forhindring av en sykdom formidlet av alfa-2B-adrenoceptor

Info

Publication number
NO20023773D0
NO20023773D0 NO20023773A NO20023773A NO20023773D0 NO 20023773 D0 NO20023773 D0 NO 20023773D0 NO 20023773 A NO20023773 A NO 20023773A NO 20023773 A NO20023773 A NO 20023773A NO 20023773 D0 NO20023773 D0 NO 20023773D0
Authority
NO
Norway
Prior art keywords
adrenoceptor
alpha
treating
preventing
compounds useful
Prior art date
Application number
NO20023773A
Other languages
English (en)
Other versions
NO20023773L (no
Inventor
Siegfried Wurster
Mia Engstroem
Liisa Huovinen
Sari Kalliokoski
Leila Kelanne
Eeva-Liisa Savola
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20000303A external-priority patent/FI20000303A0/fi
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Publication of NO20023773L publication Critical patent/NO20023773L/no
Publication of NO20023773D0 publication Critical patent/NO20023773D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20023773A 2000-02-11 2002-08-09 Forbindelser anvendbare for behandling eller forhindring av en sykdom formidlet av alfa-2B-adrenoceptor NO20023773D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18202100P 2000-02-11 2000-02-11
FI20000303A FI20000303A0 (fi) 2000-02-14 2000-02-14 Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
PCT/FI2001/000105 WO2001058454A1 (en) 2000-02-11 2001-02-07 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor

Publications (2)

Publication Number Publication Date
NO20023773L NO20023773L (no) 2002-08-09
NO20023773D0 true NO20023773D0 (no) 2002-08-09

Family

ID=26160944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023773A NO20023773D0 (no) 2000-02-11 2002-08-09 Forbindelser anvendbare for behandling eller forhindring av en sykdom formidlet av alfa-2B-adrenoceptor

Country Status (22)

Country Link
EP (1) EP1253926A1 (no)
JP (1) JP2003522148A (no)
KR (1) KR20020080413A (no)
AU (1) AU780802B2 (no)
BR (1) BR0108221A (no)
CA (1) CA2399421A1 (no)
CZ (1) CZ20022884A3 (no)
EA (1) EA200200846A1 (no)
EE (1) EE200200435A (no)
GE (1) GEP20043356B (no)
HR (1) HRP20020746A2 (no)
HU (1) HUP0300032A3 (no)
IL (1) IL151017A0 (no)
IS (1) IS6476A (no)
MX (1) MXPA02007454A (no)
MY (1) MY133957A (no)
NO (1) NO20023773D0 (no)
NZ (1) NZ520500A (no)
PL (1) PL357872A1 (no)
SK (1) SK11472002A3 (no)
WO (1) WO2001058454A1 (no)
YU (1) YU59102A (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI116940B (fi) 2001-07-20 2006-04-13 Juvantia Pharma Ltd Oy Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
NZ530366A (en) * 2001-07-20 2005-02-25 Juvantia Pharma Ltd Oy Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8416432D0 (en) * 1984-06-28 1984-08-01 Wyeth John & Brother Ltd Benzoquinolizines
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US6150389A (en) * 1994-07-11 2000-11-21 Allergan Sales, Inc. Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents

Also Published As

Publication number Publication date
CA2399421A1 (en) 2001-08-16
SK11472002A3 (sk) 2003-02-04
HRP20020746A2 (en) 2004-12-31
GEP20043356B (en) 2004-04-13
HUP0300032A2 (en) 2003-05-28
EP1253926A1 (en) 2002-11-06
HUP0300032A3 (en) 2006-01-30
IL151017A0 (en) 2003-02-12
JP2003522148A (ja) 2003-07-22
EA200200846A1 (ru) 2002-12-26
AU3551001A (en) 2001-08-20
YU59102A (sh) 2005-11-28
IS6476A (is) 2002-07-19
EE200200435A (et) 2003-12-15
NO20023773L (no) 2002-08-09
AU780802B2 (en) 2005-04-21
MY133957A (en) 2007-11-30
BR0108221A (pt) 2003-03-05
NZ520500A (en) 2005-01-28
KR20020080413A (ko) 2002-10-23
WO2001058454A1 (en) 2001-08-16
MXPA02007454A (es) 2004-08-23
PL357872A1 (en) 2004-07-26
CZ20022884A3 (cs) 2003-02-12

Similar Documents

Publication Publication Date Title
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
DE60028430D1 (de) Spielvorrichtung
DE60316379D1 (de) Landwirtschaftliche Maschine
FI990162A (fi) Puunkäsittelykone
ATE350454T1 (de) Textilbehandlungsmittel
NO20032122L (no) Forbedret behandling
DE60037233D1 (de) Hämofiltrationsvorrichtung
NO20014926L (no) Farmasöytiske forbindelser
ATE362959T1 (de) Wäschebehandlungsmittel
DE69940408D1 (de) Rolltreppe
NO20023773L (no) Forbindelser anvendbare for behandling eller forhindring av en sykdom formidlet av alfa-2B-adrenoceptor
ATA170799A (de) Schmiedemaschine
ATE234832T1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl- aminomethylchroman-derivate
DE60019183D1 (de) Fahrradpedal
DE60020000D1 (de) Spielvorrichtung
FI20011560A (fi) Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
DE10242426A8 (de) Landwirtschaftliche Maschine
DE50203244D1 (de) Gleisbaumaschine
DE50004957D1 (de) Kurzketten-Schärmaschine
DE50010738D1 (de) Zahnradmaschine
ES1049666Y (es) Maquina curvadora perfeccionada
ES1048062Y (es) Maquina de arar.
FI20000303A0 (fi) Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet
ATA2502002A (de) Heuwerbungsmaschine
IT247019Y1 (it) Macchina garzatrice

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application